Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial
Resource Type
Article
Authors
Miguel, Jesus San ; Weisel, Katja ; Moreau, Philippe ; Lacy, Martha ; Song, Kevin ; Delforge, Michel ; Karlin, Lionel ; Goldschmidt, Hartmut ; Banos, Anne ; Oriol, Albert ; Alegre, Adrian ; Chen, Christine ; Cavo, Michele ; Garderet, Laurent ; Ivanova, Valentina ; Martinez-Lopez, Joaquin ; Belch, Andrew ; Palumbo, Antonio ; Schey, Stephen ; Sonneveld, Pieter ; Yu, Xin ; Sternas, Lars ; Jacques, Christian ; Zaki, Mohamed ; Dimopoulos, Meletios
Source
In The Lancet Oncology October 2013 14(11):1055-1066
Subject
Primary Research Articles
Language
ISSN
1470-2045